|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_ocn300788959 |
003 |
OCoLC |
005 |
20231117015211.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
090131s1988 caua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d UBY
|d IDEBK
|d E7B
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d DEBSZ
|d LEAUB
|d VLY
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 505146039
|a 646758442
|a 1162091082
|
020 |
|
|
|a 9780080583679
|q (electronic bk.)
|
020 |
|
|
|a 0080583679
|q (electronic bk.)
|
020 |
|
|
|a 0120405237
|q (electronic bk.)
|
020 |
|
|
|a 9780120405237
|q (electronic bk.)
|
020 |
|
|
|a 1281739863
|
020 |
|
|
|a 9781281739865
|
020 |
|
|
|a 9786611739867
|
020 |
|
|
|a 6611739866
|
035 |
|
|
|a (OCoLC)300788959
|z (OCoLC)505146039
|z (OCoLC)646758442
|z (OCoLC)1162091082
|
050 |
|
4 |
|a RS402
|b .A65eb vol. 23
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.19
|2 22
|
245 |
0 |
0 |
|a Annual reports in medicinal chemistry.
|n Volume 23 /
|c section editors, Joel G. Berger [and others].
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c �1988.
|
300 |
|
|
|a 1 online resource (390 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Annual reports in medicinal chemistry ;
|v v. 23
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Annual Reports in Medicinal Chemistry, Volume 23; Copyright Page; CONTENTS; CONTRIBUTORS; PREFACE; SECTION I: CNS AGENTS; Chapter 1. Antipsychotic Agents; Chapter 2. Analgesics; Chapter 3. Antianxiety Agents and Anticonvulsants; Chapter 4. Agents for the Treatment of Cognitive Disorders; Chapter 5. Central Nervous System Actions of Adenosine Agonists and Antagonists; Chapter 6. Central Serotonin Receptors: Opportunities for Drug Discovery; SECTION II: CARDIOPULMONARY AND VASCULAR AGENTS; Chapter 7. Antihypertensive Agents; Chapter 8. Pulmonary and Antiallergy Agents
|
505 |
8 |
|
|a Chapter 9. Peripheral Actions of Selective Muscarinic Agonists and AntagonistsChapter 10. Vasopressin Antagonists; Chapter 11. Atrial Natriuretic Peptide; Chapter 12. Plasminogen Activators; SECTION III: CHEMOTHERAPEUTIC AGENTS; Chapter 13. Beta-Lactam Antibiotics; Chapter 14. Quinolone Antibacterial Agents; Chapter 15. Novel Approaches Toward Discovery of Antibacterial Agents; Chapter 16. Chemical Modification of Antibodies for Cancer Chemotherapy; Chapter 17. Antiviral Agents; SECTION IV: ENDOCRINOLOGY, IMMUNOLOGY AND METABOLIC DISORDERS
|
505 |
8 |
|
|a Chapter 18. Immunomodulatory Approaches to the Treatment of InflammationChapter 19. Modulation of Arachidonic Acid Metabolism in the Treatment of Rheumatoid Arthritis; Chapter 20. The Pharmacological Treatment of Obesity; Chapter 21. Gastrointestinal Motility Enhancing Agents; Chapter 22. Luteinizing Hormone Releasing Hormone Analogs In Control of Fertility and Gonadal Hormone Dependent Disease; SECTION V: TOPICS IN BIOLOGY; Chapter 23. Structure and Function of G-Protein Coupled Receptors; Chapter 24. G-proteins as Receptor-Effector Couplers; Chapter 25. Isozymes of Protein Kinase C
|
505 |
8 |
|
|a Chapter 26. Therapeutic Strategies in the Treatment of AIDSChapter 27. Enzyme Changes Linked to Anticancer Drug Resistance; SECTION VI: TOPICS IN CHEMISTRY AND DRUG DESIGN; Chapter 28. Applications of NMR Spectroscopy to Protein Structure Determination; Chapter 29. Search Strategies for Determining Bioactive Conformers of Peptides and Small Molecules; Chapter 30. Oligonucleotide Inhibitors of Gene Expression in Living Cells: New Opportunities in Drug Design; Chapter 31. Enzyme Assisted Transformations in Organic Media
|
505 |
8 |
|
|a Chapter 32. Mechanistic Aspects of Xenobiotic Metabolism as Related to Drug DesignSECTION VII: SPECIAL TOPICS; Chapter 33. To Market, To Market -- 1987; COMPOUND NAME, CODE NUMBER AND SUBJECT INDEX; CUMULATIVE CHAPTER TITLES KEYWORD INDEX, VOLUMES 1-23; CUMULATIVE CONTRIBUTOR INDEX, VOLUMES 1-23; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1987; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1987, BY INDICATION
|
520 |
|
|
|a ANNUAL REPORTS IN MED CHEMISTRY V23 PPR.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
0 |
|a Clinical chemistry.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
2 |
|a Chemistry, Clinical
|0 (DNLM)D002624
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
6 |
|a Chimie clinique.
|0 (CaQQLa)201-0016714
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Clinical chemistry.
|2 fast
|0 (OCoLC)fst00864330
|
650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
700 |
1 |
|
|a Berger, Joel G.
|
710 |
2 |
|
|a American Chemical Society.
|b Division of Medicinal Chemistry.
|
776 |
0 |
8 |
|i Print version:
|t Annual reports in medicinal chemistry. Volume 23.
|d San Diego : Academic Press, �1988
|z 9780120405237
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120405237
|z Texto completo
|